Thoughts- fund managers MUST put some US MJ stocks into their holdings. And mainstream retail investors like to jump on popular bandwagons. There are literally NO US MJ / Hemp pure play emerging growth stocks on the big boards besides Tilray and Cronos at this time. Investors will start looking to the OTC where 99% of them exist, for the value plays.
IMO Freedom Leaf should shoot for Nasdaq uplist. this company has as much rev potential and is as well run, as those two. Not just due to the business model, but also due to the very business-minded CEO running it + his current onboard connections (Pelosi, State senator, and now a PE firm).
An IPO plan would be well received by underwriters at this time. JMO.
BTW I would not buy those two big board stocks for a long term hold, but may be good for swing plays. already well overvalued. wait for pullbacks.
FRLF = pure undervalued play with massive upside.
Want to see what I'm working on? click my profile link and go to the recent posts tab. good luck and good trading all-
